This inventor holds 2 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 2 EPO patents. Top assignees: Gruenenthal Gmbh, Grunenthal Gmbh. Active years: 2016-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2021
Title: Ashish Hemani: Innovator in Pharmaceutical Dosage Forms
Introduction
Ashish Hemani is a notable inventor based in Wiltshire, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. With a total of 2 patents to his name, Hemani's work is recognized for its potential impact on medication administration.
Latest Patents
Hemani's latest patents focus on pharmaceutical dosage forms that incorporate 6'-fluoro-(N-methyl- or N,N-dimethyl-)-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine. These formulations are designed for administration twice daily, once daily, or less frequently, and include a physiologically acceptable salt of the compound. His innovative approach aims to enhance the efficacy and convenience of pharmaceutical treatments.
Career Highlights
Throughout his career, Ashish Hemani has worked with prominent companies in the pharmaceutical industry, including Gruenenthal GmbH. His experience in these organizations has allowed him to refine his expertise in drug formulation and development.
Collaborations
Some of Hemani's notable coworkers include Nadja Gruening and Marc Schiller. Their collaborative efforts have contributed to advancements in pharmaceutical research and development.
Conclusion
Ashish Hemani's contributions to pharmaceutical dosage forms demonstrate his commitment to innovation in the field. His patents reflect a dedication to improving medication delivery and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

